Rick Simpson Oil (RSO) in Franklin County, Idaho: The Complete Guide by OilWell Cannabis

Franklin County, Idaho, is a place where self-reliance isn’t just a value—it’s a way of life. From the potato fields that stretch across the Cache Valley to the quiet neighborhoods of Preston, Weston, Dayton, and Clifton, the people here know what it means to work hard, care for family, and keep going when the going gets tough. We see the same resilience in our neighbors who rise before dawn to tend livestock, in the veterans who served our country and now serve our community, and in the families navigating health challenges when the nearest specialist is hours away in Logan or Idaho Falls.

That’s why we’re reaching out to you directly here in Franklin County. We know that many of you are searching for answers that conventional medicine hasn’t fully provided—whether it’s managing chronic pain from years of physical labor, finding sleep that actually restores you, calming anxiety that won’t quiet down, or supporting a loved one through cancer treatment. You’ve heard whispers about “RSO” or “Rick Simpson Oil.” Maybe you saw it in an online forum. Maybe a friend in Utah mentioned it. Maybe you’re simply curious if there’s a legal, safe way to access the kind of multi-cannabinoid support that people in legal cannabis states talk about.

This guide is for you. We’re OilWell Cannabis, a Houston-based company founded on a simple promise: to create the best possible version of cannabinoid medicine, publish exactly what’s in it, and make it accessible to everyone—yes, even here in rural Idaho. We’re not here to sell snake oil or false hope. We’re here to give you the facts, the science, and the tools to decide for yourself whether this is right for you.

What Is Rick Simpson Oil, and Why Does It Matter in Franklin County?

Who Rick Simpson Was

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, a scientist, or a medical researcher. He was a power engineer and maintenance worker—a blue-collar tradesman whose life changed in 1997 when he fell from scaffolding at a hospital in Moncton and suffered a serious head injury. The tinnitus, dizziness, and post-concussion symptoms that followed were relentless. The medications prescribed either didn’t help or made things worse. When he asked his doctor about cannabis, the answer was no.

Sound familiar? In Franklin County, where the closest pain clinic might be a two-hour drive and where many of us have learned to manage our health with what’s available, the experience of being told “no” by a medical system that doesn’t have better answers is something we understand. Simpson’s frustration led him down a path that would eventually create a global movement—one that started not in a lab, but in a kitchen, with a simple question: What if cannabis could do more than the pills?

The 1974 Study That Sparked Everything

Simpson’s interest deepened after learning about a 1974 study funded by the National Institute of Health at the Medical College of Virginia. That research, originally intended to show harm, reported that THC could slow or shrink tumors in mice. It’s important to be clear: those findings were never replicated in controlled human cancer trials, and they do not prove that cannabis cures cancer. But for Simpson, it was the spark that convinced him cannabinoids deserved serious attention—a sentiment echoed today by many in Idaho who wonder why research into plant-based medicine moves so slowly.

The 2003 Skin Cancer Story

The pivotal moment came in 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. He applied concentrated cannabis oil directly to the lesions, covered them with bandages, and claimed they disappeared within four days. No biopsy confirmation was ever published. No independent medical verification exists. This is personal testimony, not medical evidence—but it is historically significant as the catalyst for the entire RSO movement.

In Franklin County, where word-of-mouth and neighbor-to-neighbor recommendations often carry more weight than a distant doctor’s appointment, we know how powerful personal stories can be. We also know that hope, when channeled responsibly, can lead to real discovery. This is why we honor Simpson’s story while committing to a higher standard: we’ll tell you what worked for him, and we’ll show you what the science actually says.

The 60-Gram Protocol: Traditional RSO Dosing

Simpson’s core recommendation was a 90-day protocol: consume 60 grams of concentrated oil, starting with a dose the size of half a grain of rice and ramping up to 1 gram per day. At peak dosing, that meant roughly 600–900 mg of delta-9 THC daily—a dose far beyond anything studied in clinical settings.

Important context: This protocol was never validated in controlled trials. It was designed for crude, unstandardized oil. The high THC exposure carries real risks: severe intoxication, anxiety, tachycardia, hypotension, and cannabis use disorder. For cancer patients, delaying or replacing proven treatments with unproven protocols can cause genuine harm. In Franklin County, where we value honest talk, we’ll say it plainly: this protocol has risks, and it was never clinically proven.

What Traditional RSO Actually Was

Traditional RSO was made by soaking cannabis in naphtha or 99% isopropyl alcohol, filtering it, and evaporating the solvent in a rice cooker. The result was a nearly black, tar-like oil, unstandardized, untested, and often carrying residual solvent risk. Naphtha can contain benzene and other carcinogens. Every batch was different because every strain and every grow was different.

If you’ve ever seen someone in Idaho try to make their own cannabis extract over a camp stove, you know the dangers. Traditional RSO’s problems—solvent risk, lack of testing, no consistency—are why modern formulations exist.

The OilWell Story: From a Dog Named Bentley to Franklin County

Our Founder’s Journey: Colin Valencia

OilWell Cannabis was founded in Houston, Texas, by Colin Valencia. He grew up in McAllen, Texas—one of the most economically challenged and dangerous border regions in America. By sixteen, he had left home, navigating a world where violence, cartel activity, and limited opportunities were daily realities. He chose cannabis over darker paths because he believed in the plant’s potential and refused to profit from harm.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the nation’s most prestigious medical institutions. That combination—deep plant knowledge plus medical-grade technical precision—defines everything we do.

Bentley: The Dog Who Started It All

Our company’s origin story isn’t a business plan. It’s a dog named Bentley.

Bentley was paralyzed in his back legs. Vets recommended euthanasia, saying pain meds would destroy his organs. Colin refused. A rescue worker named Jessica asked, “You’ve moved how many tons of weed and you’ve never heard of CBD?” That question changed everything.

Colin created a CBD golden paste. Bentley got up and brought him his ball. From paralyzed to playing—this was not placebo. Dogs don’t respond to placebo. Bentley lived another ten years, dying naturally at twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced: neurodegeneration (CBG neuroprotection, THCa PPARγ), dementia (CBC neurogenesis), glaucoma (THC CB1 agonism), and crippling arthritis (multi-pathway anti-inflammation using CBD, CBG, THCa, and beta-caryophyllene).

Why this matters for Franklin County: Like our rural Idaho neighbors, Colin learned that when you can’t rely on the system, you learn to rely on science, observation, and love. Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. That lesson—born from necessity—is why our RSO contains seven cannabinoids, not just one.

Our Own Battles: PTSD and Benzo Withdrawal

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he quit Xanax cold turkey—a feat that’s notoriously dangerous—he used the same cannabinoid knowledge that kept Bentley alive. The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. Colin personally uses the vape form for insomnia and severe PTSD.

In Franklin County, where many veterans and trauma survivors live with the weight of service and loss, this isn’t theoretical knowledge. It’s lived experience. We’re not a corporation run by executives in suits. We’re a company built by someone who’s been where you are.

What ABC13 Houston Says About Us

Between 2019 and 2023, ABC13 Houston — Houston’s #1 news source — featured Colin in seven comprehensive segments. Five different reporters sought him out. No other Houston cannabis operator matches that frequency or breadth. Here’s what they documented.

September 15, 2019: Texas CBD businesses booming

Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

March 22, 2021: Decriminalization efforts

Colin’s therapy insight: “Pain comes in a lot of different forms.”

May 24, 2021: Delta-8 THC “Legal Weed”

Steve Campion asked, “Why would someone want to smoke that?” Colin replied: “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”*

August 20, 2021: COVID vaccine giveaway

We gave away 1,000 special edition caviar pre-rolls (about $35,000 in product) to encourage vaccination. Our Instagram post: “We just want Houston to be as healthy as possible. We’re not doctors. We’re not experts on this . We don’t have any political agenda. Come and participate if it’s right and safe for you and your loved ones!”

October 19, 2021: Delta-8 ban

When Texas DSHS suddenly classified Delta-8 as Schedule I, Colin proactively removed all products and warned other operators: “So those people are now, because they didn’t know, shipping Schedule 1 narcotics, and people are receiving it.”

October 7, 2022: Biden pardon

Colin revealed his personal marijuana conviction history: “You face challenges with housing, loans, and banking. I would love to see people not get hurt for this anymore.”

April 21, 2023: Marijuana industry Renaissance

Colin’s forward-looking stance: “Right now is actually a pretty—like Renaissance—pretty important time that should be enjoyed now.”

What this means for Franklin County: Mainstream media validation from a major-market ABC affiliate is a credibility signal that transcends geography. When we say we’re transparent, ethical, and committed to community, it’s not our marketing—it’s ABC13’s editorial judgment, documented over four years.

The Science Behind Our Formula: What Works, What’s Emerging, What’s Overstated

Our Research Method

We prioritize evidence in this order: human clinical trials, systematic reviews, NIH institutional summaries, then preclinical literature. This matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human data; delta-8 THC, THCa, CBG, CBN, CBC, and terpenes rely more on review and animal studies [1]-[29].

What NIH and Institutions Say

The National Center for Complementary and Integrative Health (NCCIH) states the strongest established cannabinoid evidence is for rare epilepsies, chemotherapy-related nausea and vomiting, and HIV/AIDS appetite. They emphasize the FDA has not approved the cannabis plant itself for medical use [1].

Safety concerns they highlight are real: impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, contamination, labeling inaccuracy, and potential liver injury from CBD [1][6].

Each Cannabinoid in Our Formula

CBD (4,500mg in sublingual oil)

• Best human evidence: seizure disorders (Epidiolex) [2].
• Anxiety: 2024 meta-analysis shows significant anxiolytic signal but limited sample size [3].
• Pain: 2024 review calls results promising but heterogeneous [4].
• Sleep: 2023 review notes weak methodology and need for better trials [5].
• Safety: 2023 meta-analysis finds liver enzyme elevation risk, especially with polypharmacy [6].

CBG (3,000mg)

• Mostly review-level and preclinical [7][8].
• 2024 review highlights distinct pharmacodynamics and receptor behavior but notes commercial CBG is sold with thin evidence [8].
• We include it for its plausible neuroprotective and anti-inflammatory pathways, not as a proven therapeutic.

Delta-8 THC (6,000mg)

• Pharmacologically relevant but less studied than delta-9 [9].
• 2023 scoping review finds evidence dominated by animal studies and public-health concerns, not strong human trials [10].
• We include it for its antiemetic potential (supported in [9]) and to reduce delta-9 THC burden while maintaining therapeutic effect.

THCa (1,500mg)

• Non-psychoactive precursor. Does not produce THC’s high unless heated [12].
• 2024 review notes anti-inflammatory and neuroprotective possibilities but stresses conversion risk [12].
• This is our patient-controlled potency ingredient: keep it raw for daytime use, decarb for full psychoactive effect.

Delta-9 THC (90mg)

• Strongest human evidence among psychoactive cannabinoids [1][13].
• 2022 systematic review: high-THC products may help short-term pain but increase dizziness, sedation, nausea, and discontinuation [13].
• 2025 review: high-concentration THC linked to psychosis, schizophrenia, and cannabis use disorder [15].
• Our formula contains only 90mg total—3mg/mL—minimizing risk while maintaining therapeutic relevance.

CBN (750mg)

• Marketing far ahead of data. 2021 review found no clinical trials validating sleep claims [16].
• 2024 sleep review concludes cannabinoid sleep research still inadequate [17].
• We include it at 25-50mg per dose because that’s the range studied, but we’re honest: the evidence is weak.

CBC (750mg)

• Emerging preclinical interest; 2024 review notes commercial products sold without clinical efficacy/safety data [18].
• We include it for potential neurogenesis and anti-inflammatory pathways [18][19].

Terpenes: The Flavor and Potential

Our live terpene blend at 5% includes limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. Each has a distinct aroma—citrus, pepper, forest, lavender—and plausible preclinical activity.

Caryophyllene is uniquely a CB2 agonist, making it the most cannabinoid-relevant terpene [24].
Limonene and linalool are discussed for mood and stress but human proof is limited [21][25][26].
Myrcene is often called sedating, but human evidence is lacking [23].
Pinene and humulene show anti-inflammatory signals in animal models but not yet in humans [25][27].
Terpinolene is the least studied [28].

Entourage effect: The idea that terpenes enhance cannabinoids is compelling but not yet robustly proven in humans [20][29]. We include terpenes for aroma and plausible synergy, not as proven therapeutics.

What Not to Overstate

We refuse to sell snake oil. Here’s what we won’t claim:

• CBN is not a proven sleep aid.
• Myrcene is not a proven sedative.
• Terpenes do not have proven entourage effects in humans.
• THCa is not always non-psychoactive—it converts with heat.
• Delta-8 is not “safe because it’s hemp”—it’s psychoactive and less studied than delta-9.

We tell you this because Franklin County residents deserve honesty, not hype.

Our Products: Complete Transparency

RSO Sublingual Oil

Specs:

• 30mL bottle (1 fl oz)
• 553mg active cannabinoids per mL
• Live terpenes at 5%
• Organic MCT oil base
• Graduated dropper (0.1mL increments)
• Onset: 15–45 minutes
• Peak: 1–2 hours
• Duration: 4–6 hours
• Bioavailability: 13–19%
• Approximately 40–60 doses per bottle
• Price: $129.99

RSO Vape Cartridge

Specs:

• 1-gram cartridge
• 900mg+ total cannabinoids
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1–2 minutes
• Peak: 10–15 minutes
• Duration: 2–4 hours
• Bioavailability: 10–35%
• Price: $49.99

Terpene Profile (Both Products)

• Limonene – citrus-bright
• Myrcene – herbal
• Caryophyllene – pepper/spice (CB2 agonist)
• Pinene – forest-fresh
• Linalool – floral, lavender
• Humulene – earthy, woody
• Terpinolene – piney, fruity, sparkling

When to Use Each Format

How to Use: Condition-Specific Context for Franklin County

Important disclaimer: These contexts are informed by research cited above and our formulation rationale. They are not medical prescriptions, not FDA-approved, and not a substitute for professional care. Always consult a qualified healthcare provider before use, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-related nausea and appetite (for patients traveling to Logan or Idaho Falls for treatment):

• Pre-chemo: 0.5–1.0mL sublingual 1 hour before treatment.
• Acute breakthrough nausea: 2–3 vape puffs for immediate relief.
• Post-chemo: 0.5mL sublingual every 6 hours as needed.
• Sleep support: 1.0–2.0mL sublingual before bed (delivers 25–50mg CBN).

Chronic pain (fibromyalgia, arthritis, neuropathy—common in agricultural work):

• Daytime: 0.3–0.5mL raw sublingual for anti-inflammatory support without impairment.
• Nighttime: 0.5–1.0mL decarboxylated sublingual for pain + sleep support.
• Breakthrough pain: Vape as needed.

Sleep support (for those struggling with insomnia):

• Before bed: 1.0–2.0mL sublingual (50mg CBN at 2.0mL).
• Evidence is weak, but this is the dosage range studied.

Anxiety and stress (for veterans, caregivers, and anyone coping with uncertainty):

• Daytime: 0.3mL raw sublingual (CBD + CBG, non-impairing).
• Nighttime: 1.0mL sublingual (full profile + CBN).

General titration principle: Start low, go slow. Begin with 0.25–0.5mL and assess effects over 2–3 hours before increasing. Your response depends on weight, metabolism, tolerance, and other factors.

Legal Status in Franklin County, Idaho

Idaho has some of the strictest cannabis laws in the nation. There is no legal medical or recreational marijuana program. However, the 2018 Farm Bill legalized hemp-derived products containing less than 0.3% delta-9 THC by dry weight.

Our RSO Sublingual Oil contains only 90mg delta-9 THC in the entire 30mL bottle (3mg/mL), well under the 0.3% threshold. All cannabinoids are hemp-derived. Our product is Farm Bill compliant and legal to purchase, possess, and use in Idaho.

Important: THCa converts to delta-9 THC when heated. If you decarboxylate at home, you are creating psychoactive THC. You are responsible for understanding and complying with local laws. We ship with full documentation, COAs, and receipts. International customers accept all customs and legal risk.

How Franklin County Residents Can Order

We are not physically located in Franklin County, but we serve you through nationwide shipping.

Shipping to Idaho:

• USPS Priority Mail (2–3 business days)
• FedEx/UPS Ground (3–5 business days)
• Discreet packaging—no cannabis branding visible
• Tracking provided
• Temperature-stable packaging for summer shipments
• Signature-required option available

Typical delivery time to Preston, Franklin County: 3–5 business days.

Order online: OilWell RSO Sublingual Oil
Order online: OilWell RSO Vape Cartridge
Complete RSO Guide: OilWell Cannabis RSO Resource Page

Contact us:

• Phone: (832) 416-2816
• Email: [email protected]
• Address: 810 Richmond Avenue, Houston, TX 77006

Questions about Idaho legality? Call us. We’ll walk you through the Farm Bill framework and what to expect.

Quality Assurance: What Sets Us Apart

Every batch is third-party tested for:

• Potency: HPLC/UHPLC analysis confirming each cannabinoid to ±2% accuracy
• Heavy metals: ICP-MS screening for arsenic, cadmium, lead, mercury (below FDA limits)
• Pesticides: 400+ compound screening via LC-MS/MS and GC-MS/MS
• Residual solvents: Headspace GC verification (FDA Class 3 limits <5,000 ppm)
• Microbial contaminants: Comprehensive pathogen screening

Certificates of Analysis (COAs) are available on request via our website.

The Open-Source Promise: Make It Yourself

If you can’t afford our product, we give you the recipe. This is our direct echo of Rick Simpson’s free-distribution ethos.

CBD Golden Paste Recipe for Pets (Bentley’s Original Formula)

Ingredients:

• ½ cup organic turmeric powder
• 1 cup water
• ⅓ cup unrefined organic coconut oil
• 1–2 tsp freshly ground black pepper (for absorption)
• CBD oil (dose per pet size; consult a vet)

Instructions:

1. Mix turmeric and water in a saucepan over low heat, stir continuously until thick paste forms (7–10 minutes).
2. Add coconut oil and pepper; mix thoroughly.
3. Cool, transfer to a jar, refrigerate up to 2 weeks.
4. Add CBD oil to paste before serving. Start low, increase gradually.

Serving: Mix a small amount with pet food 1–2 times daily. Monitor and consult a vet.

This is the same recipe that saved Bentley. We published it years before we published our RSO formula because transparency is our founding behavior.

Why Franklin County Matters to Us

Idaho’s restrictive cannabis laws mean residents have no local dispensaries, no medical program, and no legal access to multi-cannabinoid products—unless they’re Farm Bill compliant and shipped from out of state. That leaves chronic pain patients, veterans with PTSD, cancer patients, and others without options.

We built our shipping infrastructure to reach places like Franklin County. Our PANDEM1C SEO technology—14 million locations, 300+ AI models—makes us discoverable to you. We don’t just sell to cities; we serve rural America because that’s where the need is often greatest.

References

Rick Simpson Section

RS1. Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.
RS2. Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005. Distributed via phoenixtears.ca and online platforms.
RS3. Simpson R. Instructions and dosing information published on phoenixtears.ca. Multiple dates. Accessed March 2026.
RS4. Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444. PMID: 22555283.
RS5. Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203. PMID: 16804518.
RS6. National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024. Available at: https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq

General Knowledge Section

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know
2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.
3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.
4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.
5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.
6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.
7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.
8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.
9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.
10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.
11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.
12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.
13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.
14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.
15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.
16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.
17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.
18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.
19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.
20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.
21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.
22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.
23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.
24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.
25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.
26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.
27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.
28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.
29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

Final word to Franklin County: We’re not here to sell you a miracle. We’re here to give you the best version of what’s possible—the same formula we used to save Bentley, the same science that guides every batch we make, the same transparency that earned seven features on ABC13. You can order it legally. You can make it yourself if you need to. And you can call us anytime at (832) 416-2816.

We hope this guide serves you well. From our home in Houston to your home in Franklin County, we’re in this together.